by The global Wound care market size was estimated to be around US$ 23.57 billion in 2023 and is projected to reach US$ 35.33 billion by 2032, indicating a CAGR of 4.40% from 2023 to 2032.
Key Takeaways
- North America contributed more than 46% of revenue share in 2022.
- Asia Pacific is estimated to expand the fastest CAGR between 2023 and 2032.
- By application, the chronic segment has held the largest market share of 75% in 2022.
- By application, the acute segment is anticipated to grow at a remarkable CAGR of 5.1% between 2023 and 2032.
- By end-use, the hospital segment generated over 39% of revenue share in 2022.
- By end-use, the home care segment is expected to expand at the fastest CAGR over the projected period.
- By product, the advanced wound dressing segment generated over 34% of revenue share in 2022.
- By product, the surgical wound care segment is expected to expand at the fastest CAGR over the projected period.
- By mode of purchase, the prescribed segment generated over 65% of revenue share in 2022.
- By mode of purchase, the non-prescribed (OTC) segment is expected to expand at the fastest CAGR over the projected period.
The market research report on the Wound care market provides a comprehensive analysis of various key aspects. It includes the definition, classification, and application of Wound care products. The report examines the development trends, competitive landscape, and industrial chain structure within the industry. Furthermore, it presents an overview of the industry, analyzes national policies and planning, and offers insights into the latest market dynamics and opportunities at a global level.
Get a Sample: https://www.precedenceresearch.com/sample/3616
Wound Care Market Scope
| Report Coverage | Details |
| Market Size in 2023 | USD 23.57 Billion |
| Market Size by 2032 | USD 35.33 Billion |
| Growth Rate from 2023 to 2032 | CAGR of 4.40% |
| Largest Market | North America |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Application, By End-use, By Product, and By Mode of Purchase |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Read More: Blood Culture Test Market Size To Grow USD 16.31 Bn By 2032
The report presents the volume and value-based market size for the base year 2022 and forecasts the market’s growth between 2023 and 2032. It estimates market numbers based on product form and application, providing size and forecast for each application segment in both global and regional markets.
Focusing on the global Wound care market, the report highlights its status, future forecasts, growth opportunities, key market players, and key market regions such as the United States, Europe, and China. The study aims to present the development of the Wound care market by considering factors like Year-on-Year (Y-o-Y) growth, in addition to Compound Annual Growth Rate (CAGR). This approach enables a better understanding of market certainty and the identification of lucrative opportunities.
Regarding production, the report investigates the capacity, production, value, ex-factory price, growth rate, and market share of major manufacturers, regions, and product types. On the consumption side, the report focuses on the regional consumption of Wound care products across different countries and applications.
Buyers of the report gain access to verified market figures, including global market size in terms of revenue and volume. The report provides reliable estimations and calculations for global revenue and volume by product type from 2023 to 2032. It also includes accurate figures for production capacity and production by region during the same period.
The research includes product parameters, production processes, cost structures, and data classified by region, technology, and application. Furthermore, it conducts SWOT analysis and investment feasibility studies for new projects.
This in-depth research report offers valuable insights into the Wound care market. It employs an objective and fair approach to analyze industry trends, supporting customer competition analysis, development planning, and investment decision-making. The project received support and assistance from technicians and marketing personnel across various links in the industry chain.
The competitive landscape section of the report provides detailed information on Wound care market competitors. It includes company overviews, financials, revenue generation, market potential, research and development investments, new market initiatives, global presence, production sites, production capacities, strengths and weaknesses, product launches, product range, and application dominance. However, the data points provided only focus on the companies’ activities related to the Wound care market.
Prominent players in the market are expected to face tough competition from new entrants. Key players are targeting acquisitions of startup companies to maintain their dominance. The report
Reasons to Purchase this Report:
- Comprehensive market segmentation analysis incorporating qualitative and quantitative research, considering the impact of economic and policy factors.
- In-depth regional and country-level analysis, examining the demand and supply dynamics that influence market growth.
- Market size in USD million and volume in million units provided for each segment and sub-segment.
- Detailed competitive landscape, including market share of major players, recent projects, and strategies implemented over the past five years.
- Comprehensive company profiles encompassing product offerings, key financial information, recent developments, SWOT analysis, and employed strategies by major market players.
Wound Care Market Players
- 3M Company
- Smith & Nephew plc
- Johnson & Johnson
- Mölnlycke Health Care
- Coloplast A/S
- ConvaTec Group plc
- B. Braun Melsungen AG
- Medtronic plc
- Acelity L.P. Inc.
- Integra LifeSciences Corporation
- Ethicon, Inc. (a subsidiary of Johnson & Johnson)
- Derma Sciences, Inc. (acquired by Integra LifeSciences)
- Misonix, Inc.
- Organogenesis Holdings Inc.
- Hollister Incorporated
Segments Covered in the Report
By Application
- Chronic
- Acute
By End-use
- Hospitals
- Specialty Clinics
- Home Healthcare
- Physician’s Office
- Nursing Homes
- Others
By Product
- Advanced Wound Dressing
- Surgical Wound Care
- Traditional Wound Care
- Wound Therapy Devices
By Mode of Purchase
- Prescribed
- Non-prescribed (OTC)
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Wound Care Market
5.1. COVID-19 Landscape: Wound Care Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Wound Care Market, By Application
8.1. Wound Care Market, by Application, 2023-2032
8.1.1. Chronic
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Acute
8.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Wound Care Market, By End-use
9.1. Wound Care Market, by End-use, 2023-2032
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Specialty Clinics
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Home Healthcare
9.1.3.1. Market Revenue and Forecast (2020-2032)
9.1.4. Physician’s Office
9.1.4.1. Market Revenue and Forecast (2020-2032)
9.1.5. Nursing Homes
9.1.5.1. Market Revenue and Forecast (2020-2032)
9.1.6. Others
9.1.6.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Wound Care Market, By Product
10.1. Wound Care Market, by Product, 2023-2032
10.1.1. Advanced Wound Dressing
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Surgical Wound Care
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Traditional Wound Care
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Wound Therapy Devices
10.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Wound Care Market, By Mode of Purchase
11.1. Wound Care Market, by Mode of Purchase, 2023-2032
11.1.1. Prescribed
11.1.1.1. Market Revenue and Forecast (2020-2032)
11.1.2. Non-prescribed (OTC)
11.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 12. Global Wound Care Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Application (2020-2032)
12.1.2. Market Revenue and Forecast, by End-use (2020-2032)
12.1.3. Market Revenue and Forecast, by Product (2020-2032)
12.1.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Application (2020-2032)
12.1.5.2. Market Revenue and Forecast, by End-use (2020-2032)
12.1.5.3. Market Revenue and Forecast, by Product (2020-2032)
12.1.5.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Application (2020-2032)
12.1.6.2. Market Revenue and Forecast, by End-use (2020-2032)
12.1.6.3. Market Revenue and Forecast, by Product (2020-2032)
12.1.6.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Application (2020-2032)
12.2.2. Market Revenue and Forecast, by End-use (2020-2032)
12.2.3. Market Revenue and Forecast, by Product (2020-2032)
12.2.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Application (2020-2032)
12.2.5.2. Market Revenue and Forecast, by End-use (2020-2032)
12.2.5.3. Market Revenue and Forecast, by Product (2020-2032)
12.2.5.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Application (2020-2032)
12.2.6.2. Market Revenue and Forecast, by End-use (2020-2032)
12.2.6.3. Market Revenue and Forecast, by Product (2020-2032)
12.2.6.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Application (2020-2032)
12.2.7.2. Market Revenue and Forecast, by End-use (2020-2032)
12.2.7.3. Market Revenue and Forecast, by Product (2020-2032)
12.2.7.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Application (2020-2032)
12.2.8.2. Market Revenue and Forecast, by End-use (2020-2032)
12.2.8.3. Market Revenue and Forecast, by Product (2020-2032)
12.2.8.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Application (2020-2032)
12.3.2. Market Revenue and Forecast, by End-use (2020-2032)
12.3.3. Market Revenue and Forecast, by Product (2020-2032)
12.3.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Application (2020-2032)
12.3.5.2. Market Revenue and Forecast, by End-use (2020-2032)
12.3.5.3. Market Revenue and Forecast, by Product (2020-2032)
12.3.5.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Application (2020-2032)
12.3.6.2. Market Revenue and Forecast, by End-use (2020-2032)
12.3.6.3. Market Revenue and Forecast, by Product (2020-2032)
12.3.6.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Application (2020-2032)
12.3.7.2. Market Revenue and Forecast, by End-use (2020-2032)
12.3.7.3. Market Revenue and Forecast, by Product (2020-2032)
12.3.7.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Application (2020-2032)
12.3.8.2. Market Revenue and Forecast, by End-use (2020-2032)
12.3.8.3. Market Revenue and Forecast, by Product (2020-2032)
12.3.8.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Application (2020-2032)
12.4.2. Market Revenue and Forecast, by End-use (2020-2032)
12.4.3. Market Revenue and Forecast, by Product (2020-2032)
12.4.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Application (2020-2032)
12.4.5.2. Market Revenue and Forecast, by End-use (2020-2032)
12.4.5.3. Market Revenue and Forecast, by Product (2020-2032)
12.4.5.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Application (2020-2032)
12.4.6.2. Market Revenue and Forecast, by End-use (2020-2032)
12.4.6.3. Market Revenue and Forecast, by Product (2020-2032)
12.4.6.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Application (2020-2032)
12.4.7.2. Market Revenue and Forecast, by End-use (2020-2032)
12.4.7.3. Market Revenue and Forecast, by Product (2020-2032)
12.4.7.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Application (2020-2032)
12.4.8.2. Market Revenue and Forecast, by End-use (2020-2032)
12.4.8.3. Market Revenue and Forecast, by Product (2020-2032)
12.4.8.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Application (2020-2032)
12.5.2. Market Revenue and Forecast, by End-use (2020-2032)
12.5.3. Market Revenue and Forecast, by Product (2020-2032)
12.5.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Application (2020-2032)
12.5.5.2. Market Revenue and Forecast, by End-use (2020-2032)
12.5.5.3. Market Revenue and Forecast, by Product (2020-2032)
12.5.5.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Application (2020-2032)
12.5.6.2. Market Revenue and Forecast, by End-use (2020-2032)
12.5.6.3. Market Revenue and Forecast, by Product (2020-2032)
12.5.6.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)
Chapter 13. Company Profiles
13.1. 3M Company
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Smith & Nephew plc
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Johnson & Johnson
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Mölnlycke Health Care
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Coloplast A/S
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. ConvaTec Group plc
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. B. Braun Melsungen AG
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Medtronic plc
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Acelity L.P. Inc.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Integra LifeSciences Corporation
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.expresswebwire.com/
Blog: https://www.uswebwire.com/
